Exscientia
identifying specific patient selection marker for | Exscientia
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
43 of 73
Related slides by other companies
Kymera
Results
December 2022
in inhibition of disease relevant plasma and acute phase reactants by in patients | Kymera
Aeglea BioTherapeutics
Investor Presentation
July 2023
leverages genetically driven patient selection to match disease drivers with therapeutic targets | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
September 2023
leverages genetically driven patient selection to match disease drivers with therapeutic targets | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Mergers and Acquisitions
June 2023
leverages genetically driven patient selection to match disease drivers with therapeutic targets | Aeglea BioTherapeutics
Other recent decks by Exscientia
See all presentations (14 decks)
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights